BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26323380)

  • 1. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
    Rensing-Ehl A; Völkl S; Speckmann C; Lorenz MR; Ritter J; Janda A; Abinun M; Pircher H; Bengsch B; Thimme R; Fuchs I; Ammann S; Allgäuer A; Kentouche K; Cant A; Hambleton S; Bettoni da Cunha C; Huetker S; Kühnle I; Pekrun A; Seidel MG; Hummel M; Mackensen A; Schwarz K; Ehl S
    Blood; 2014 Aug; 124(6):851-60. PubMed ID: 24894771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene.
    Miano M; Cappelli E; Pezzulla A; Venè R; Grossi A; Terranova P; Palmisani E; Maggiore R; Guardo D; Lanza T; Calvillo M; Micalizzi C; Pierri F; Vernarecci C; Beccaria A; Corsolini F; Lanciotti M; Russo G; Ceccherini I; Dufour C; Fioredda F
    Br J Haematol; 2019 Nov; 187(4):502-508. PubMed ID: 31309545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
    Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
    Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
    Cerutti E; Campagnoli MF; Ferretti M; Garelli E; Crescenzio N; Rosolen A; Chiocchetti A; Lenardo MJ; Ramenghi U; Dianzani U
    BMC Immunol; 2007 Nov; 8():28. PubMed ID: 17999750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).
    Lisco A; Wong CS; Price S; Ye P; Niemela J; Anderson M; Richards E; Manion M; Mystakelis H; Similuk M; Lo B; Stoddard J; Rosenzweig S; Vanpouille C; Rupert A; Maric I; Perez-Diez A; Parenti D; Burbelo PD; Rao VK; Sereti I
    Front Immunol; 2019; 10():1193. PubMed ID: 31191551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
    Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
    Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome.
    Völkl S; Rensing-Ehl A; Allgäuer A; Schreiner E; Lorenz MR; Rohr J; Klemann C; Fuchs I; Schuster V; von Bueren AO; Naumann-Bartsch N; Gambineri E; Siepermann K; Kobbe R; Nathrath M; Arkwright PD; Miano M; Stachel KD; Metzler M; Schwarz K; Kremer AN; Speckmann C; Ehl S; Mackensen A
    Blood; 2016 Jul; 128(2):227-38. PubMed ID: 27099149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological findings in human autoimmune lymphoproliferative syndrome.
    Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
    Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.
    Juvet SC; Thomson CW; Kim EY; Han M; Zhang L
    PLoS One; 2013; 8(6):e65253. PubMed ID: 23762329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical presentation of autoimmune lymphoproliferative syndrome due to CASP10 mutation.
    Tripodi SI; Mazza C; Moratto D; Ramenghi U; Caorsi R; Gattorno M; Badolato R
    Immunol Lett; 2016 Sep; 177():22-4. PubMed ID: 27378136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FcRγ promotes T cell apoptosis in Fas-deficient mice.
    Juvet SC; Thomson CW; Kim EY; Joe B; Adeyi O; Zhang L
    J Autoimmun; 2013 May; 42():80-93. PubMed ID: 23313147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.